SAINT BELLA GROUP LIMITED disclosed on 22 June 2026 that it has completed the RMB22.40 million acquisition of minority equity interests in four postpartum care entities linked to Wuhan Fu Lei Ya Health Management Company. The transaction strengthens the Group’s footprint in Central China and supports its dual-engine strategy of organic growth and external mergers and acquisitions.

The acquired interests comprise: • 30% of Wuhan He’an Maternal and Infant Care Co., Ltd. • 30% of Wuhan Chen’yue Maternal and Infant Care Co., Ltd. • 40% of Wuhan Jiayuehui Health Consultancy Co., Ltd. • 40% of Wuhan Fenghua Health Consultancy Co., Ltd.

SAINT BELLA will control the boards of the first three companies, leading to their full consolidation into the Group’s financial statements.

An earn-out mechanism gives SAINT BELLA the right to lift its stakes to 60%–80% in the target companies at the same price-to-earnings multiple, conditional on the businesses meeting agreed performance targets within a specified period.

Fu Lei Ya, founded in 2013, operates three high-end postpartum centres in Wuhan’s core business districts. Its network offers more than 160 care rooms at an average selling price close to RMB50,000 and has served almost 10,000 high-net-worth families, commanding the city’s top market share in premium maternal and infant care.

Management views the deal as strategically significant in four areas:

1. Central-China expansion: Entry into Wuhan, a key economic hub, accelerates SAINT BELLA’s move from coastal first-tier to inland core cities. 2. Membership growth and synergy: Nearly 10,000 Fu Lei Ya clients will be added to SAINT BELLA’s ecosystem, supporting the postpartum centre, family care and women’s health food segments. 3. Brand matrix enhancement: Fu Lei Ya’s local recognition complements SAINT BELLA’s existing “Saint Bella,” “Bella Isla” and “Baby Bella” brands, facilitating a multilayer brand strategy. 4. M&A track record: Following prior deals involving GuangHeTang and Shanghai Yuezige, the Wuhan acquisition underscores SAINT BELLA’s ability to execute cross-regional, replicable consolidation.

The Board considers the terms fair and believes the transaction will bolster scale and profitability. All Listing Rule percentage ratios are below 5%, so the deal does not constitute a disclosable transaction. Investors are advised to exercise caution when dealing in SAINT BELLA securities.